Wells Fargo Reports Second Quarter 2024 Financial Results | Business
SAN FRANCISCO--(BUSINESS WIRE)--Jul 12, 2024--Wells Fargo & Company (NYSE: WFC) has released its second quarter 2024 financial results. The financial...
SAN FRANCISCO--(BUSINESS WIRE)--Jul 12, 2024--Wells Fargo & Company (NYSE: WFC) has released its second quarter 2024 financial results. The financial...
- Received U.S. Food and Drug Administration ("FDA") Breakthrough Therapy Designation ("BTD") for CYB003, its proprietary deuterated psilocybin analog in...
CRISPR Therapeutics AG-More than 25 authorized treatment centers (ATCs) activated globally for CASGEVY™ and multiple patients have already had cells...
iTeos Therapeutics Inc.- Belrestotug + dostarlimab exceeded pre-defined efficacy criteria for clinically relevant activity observed in an interim assessment of...
Corvus Pharmaceuticals, Inc.Soquelitinib Phase 1 Randomized Trial in Atopic Dermatitis Enrolling at Multiple Centers; Potential for Early Data Before Year-End...